| Symbol |
Name |
|
ACVR1B
|
activin A receptor, type IB
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADAM15
|
ADAM metallopeptidase domain 15
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
APBB1
|
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65)
|
|
APBB2
|
amyloid beta (A4) precursor protein-binding, family B, member 2
|
|
ARHGAP4
|
Rho GTPase activating protein 4
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BDKRB1
|
bradykinin receptor B1
|
|
BMP10
|
bone morphogenetic protein 10
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
BTG1
|
B-cell translocation gene 1, anti-proliferative
|
|
C10ORF90
|
chromosome 10 open reading frame 90
|
|
CAPRIN2
|
caprin family member 2
|
|
CAV3
|
caveolin 3
|
|
CCDC85B
|
coiled-coil domain containing 85B
|
|
CDA
|
cytidine deaminase
|
|
CDHR2
|
cadherin-related family member 2
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35)
|
|
CDKL3
|
cyclin-dependent kinase-like 3
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2AIP
|
CDKN2A interacting protein
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
|
CDKN2D
|
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)
|
|
CGREF1
|
cell growth regulator with EF-hand domain 1
|
|
CRLF3
|
cytokine receptor-like factor 3
|
|
CRYAB
|
crystallin, alpha B
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
DACT3
|
dishevelled-binding antagonist of beta-catenin 3
|
|
DCBLD2
|
discoidin, CUB and LCCL domain containing 2
|
|
DCC
|
DCC netrin 1 receptor
|
|
DCSTAMP
|
dendrocyte expressed seven transmembrane protein
|
|
DCUN1D3
|
DCN1, defective in cullin neddylation 1, domain containing 3
|
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked
|
|
DNAJB2
|
DnaJ (Hsp40) homolog, subfamily B, member 2
|
|
DNAJC2
|
DnaJ (Hsp40) homolog, subfamily C, member 2
|
|
DRAXIN
|
dorsal inhibitory axon guidance protein
|
|
EAF2
|
ELL associated factor 2
|
|
EI24
|
etoposide induced 2.4
|
|
ENO1
|
enolase 1, (alpha)
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
FBP1
|
fructose-1,6-bisphosphatase 1
|
|
FGF13
|
fibroblast growth factor 13
|
|
FHL1
|
four and a half LIM domains 1
|
|
FLCN
|
folliculin
|
|
FOXK1
|
forkhead box K1
|
|
FRZB
|
frizzled-related protein
|
|
GAL
|
galanin/GMAP prepropeptide
|
|
GAS1
|
growth arrest-specific 1
|
|
GDF2
|
growth differentiation factor 2
|
|
GDF9
|
growth differentiation factor 9
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GNG4
|
guanine nucleotide binding protein (G protein), gamma 4
|
|
GREM1
|
gremlin 1, DAN family BMP antagonist
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HRG
|
histidine-rich glycoprotein
|
|
HYAL1
|
hyaluronoglucosaminidase 1
|
|
HYAL2
|
hyaluronoglucosaminidase 2
|
|
ING1
|
inhibitor of growth family, member 1
|
|
INHBA
|
inhibin, beta A
|
|
IP6K2
|
inositol hexakisphosphate kinase 2
|
|
JADE1
|
jade family PHD finger 1
|
|
LMTK1
|
lemur tail kinase 1
|
|
MSX1
|
msh homeobox 1
|
|
MT3
|
metallothionein 3
|
|
MUL1
|
mitochondrial E3 ubiquitin protein ligase 1
|
|
MYL2
|
myosin, light chain 2, regulatory, cardiac, slow
|
|
NAIF1
|
nuclear apoptosis inducing factor 1
|
|
NDRG3
|
NDRG family member 3
|
|
NDUFA13
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13
|
|
NDUFS3
|
NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kDa (NADH-coenzyme Q reductase)
|
|
NME6
|
NME/NM23 nucleoside diphosphate kinase 6
|
|
NPPA
|
natriuretic peptide A
|
|
NPPB
|
natriuretic peptide B
|
|
NPR1
|
natriuretic peptide receptor 1
|
|
NRP1
|
neuropilin 1
|
|
NTN1
|
netrin 1
|
|
OSGIN1
|
oxidative stress induced growth inhibitor 1
|
|
PHB
|
prohibitin
|
|
PI16
|
peptidase inhibitor 16
|
|
PLXNA3
|
plexin A3
|
|
PML
|
promyelocytic leukemia
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPP1R9B
|
protein phosphatase 1, regulatory subunit 9B
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PPP2R1A
|
protein phosphatase 2, regulatory subunit A, alpha
|
|
PPT1
|
palmitoyl-protein thioesterase 1
|
|
PSRC1
|
proline/serine-rich coiled-coil 1
|
|
PTPRJ
|
protein tyrosine phosphatase, receptor type, J
|
|
RBBP7
|
retinoblastoma binding protein 7
|
|
RERG
|
RAS-like, estrogen-regulated, growth inhibitor
|
|
RNF6
|
ring finger protein (C3H2C3 type) 6
|
|
RTN4
|
reticulon 4
|
|
SCGB3A1
|
secretoglobin, family 3A, member 1
|
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
|
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F
|
|
SEMA4F
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4F
|
|
SEMA5A
|
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A
|
|
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2
|
|
SERTAD2
|
SERTA domain containing 2
|
|
SERTAD3
|
SERTA domain containing 3
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SH3BP4
|
SH3-domain binding protein 4
|
|
SIPA1
|
signal-induced proliferation-associated 1
|
|
SIRT1
|
sirtuin 1
|
|
SLIT1
|
slit homolog 1 (Drosophila)
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
|
SLIT3
|
slit homolog 3 (Drosophila)
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SOX17
|
SRY (sex determining region Y)-box 17
|
|
SPG20
|
spastic paraplegia 20 (Troyer syndrome)
|
|
SPP1
|
secreted phosphoprotein 1
|
|
ST7L
|
suppression of tumorigenicity 7 like
|
|
STK11
|
serine/threonine kinase 11
|
|
TCHP
|
trichoplein, keratin filament binding
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TNK1
|
tyrosine kinase, non-receptor, 1
|
|
TNR
|
tenascin R
|
|
TP53
|
tumor protein p53
|
|
TP53TG5
|
TP53 target 5
|
|
TRIM40
|
tripartite motif containing 40
|
|
TRO
|
trophinin
|
|
TSPYL2
|
TSPY-like 2
|
|
ULK1
|
unc-51 like autophagy activating kinase 1
|
|
ULK2
|
unc-51 like autophagy activating kinase 2
|
|
WFDC1
|
WAP four-disulfide core domain 1
|
|
WNT11
|
wingless-type MMTV integration site family, member 11
|
|
WNT3
|
wingless-type MMTV integration site family, member 3
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WT1
|
Wilms tumor 1
|